TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral TG-1000.

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

The opioid crisis has taken the lives of thousands of people in our country. In fact, according to the CDC, opioid overdose deaths hit...

L.A. Care Health Plan and Blue Shield of California Promise Health Plan's network of Community Resource Centers are offering drive-thru flu shot clinics across Los Angeles County